Abstract: Systems and methods permit remote endoscope handle manipulation. This can include a control housing configured to removably attach to an endoscope. A manipulator, associated with the housing, can be configured to engage with a control device of the endoscope with the endoscope attached to the housing. An actuator, drivingly coupled with the manipulator, can be configured to move the manipulator to operate the control device with the endoscope attached to the housing.
Type:
Grant
Filed:
February 6, 2009
Date of Patent:
April 2, 2013
Assignee:
The Trustees of Columbia University in the City of New York
Abstract: Composition and methods of treating pain and reducing or reversing tolerance to opiate analgesics are disclosed. The composition and method utilize an opiate analgesic and an endothelin antagonist as active agents to treat pain in mammals, including humans.
Type:
Grant
Filed:
August 2, 2010
Date of Patent:
April 2, 2013
Assignee:
The Board of Trustees of the University of Illinois
Abstract: Photonic band gap fibers are described having one or more defects suitable for the acceleration of electrons or other charged particles. Methods and devices are described for exciting special purpose modes in the defects including laser coupling schemes as well as various fiber designs and components for facilitating excitation of desired modes. Results are also presented showing effects on modes due to modes in other defects within the fiber and due to the proximity of defects to the fiber edge. Techniques and devices are described for controlling electrons within the defect(s). Various applications for electrons or other energetic charged particles produced by such photonic band gap fibers are also described.
Type:
Grant
Filed:
August 2, 2010
Date of Patent:
April 2, 2013
Assignee:
The Board of Trustees of the Leland Stanford Junior University
Inventors:
James Spencer, Robert Noble, Sara Campbell
Abstract: A nucleic acid enzyme responsive to copper, comprising an oligonucleotide comprising a nucleotide sequence of SEQ ID NO:1, wherein the nucleic acid enzyme is not self-cleaving.
Type:
Grant
Filed:
July 16, 2008
Date of Patent:
April 2, 2013
Assignee:
The Board of Trustees of the University of Illinois
Abstract: This invention contemplates an accurate and efficient estimation of gene copy number using oligonucleotide microarrays. The method integrates gene copy number data obtained from perfect match and mismatch probe sequence structure intensities and probe binding affinities. In one embodiment, an accurate determination of single nucleotide polymorphisms (SNPs) sequences is obtained. In another embodiment, an accurate detection and determination of DNA copy number alteration is obtained. In another embodiment, an accurate estimation for RNA gene expression is obtained.
Type:
Grant
Filed:
April 7, 2010
Date of Patent:
April 2, 2013
Assignee:
Board of Trustees of Michigan State University
Abstract: The present invention relates to omega-3 diglyceride emulsions characterized in that the lipid phase comprises at least about 40 wt.-% of diglycerides. Preferably about 70 wt. -% of the acyl-groups of said diglycerides, are eicosapentaenoic acid (EPA) groups and/or docosahexaenoic (DHA) groups. The invention further relates to methods of treatment using the omega-3 diglyceride emulsions.
Type:
Grant
Filed:
September 19, 2007
Date of Patent:
April 2, 2013
Assignee:
The Trustees of Columbia University in the City of New York
Abstract: Systems and methods for enhancing symmetry in 2D and 3D objects are disclosed. At least some embodiments include a computer-readable storage medium including software (executable on a processor) to symmetrize a modeled physical object that causes the processor to identify a plurality of clusters (each including a plurality of symmetric point pairs each derived from a plurality of sampled surface points of the object), and to calculate and apply each of a first plurality of displacement value pairs to corresponding sample positions of the symmetric point pairs within at least one cluster, increasing the symmetry of the cluster. The software further causes the processor to calculate a second plurality of displacement value pairs, to contract the cluster using the second plurality of displacement value pairs, to merge two or more clusters within the transformation space, and to present a graphical representation of the symmetrized modeled physical object to a user.
Type:
Grant
Filed:
June 9, 2009
Date of Patent:
April 2, 2013
Assignee:
The Board of Trustees of the Leland Stanford Jr. University
Inventors:
Niloy J. Mitra, Leonidas J. Guibas, Mark Pauly
Abstract: The invention generally relates to improved methods for treatment or prophylaxis in animal subjects (including humans) of autoimmune disorders including Type I diabetes, septic shock, multiple sclerosis, inflammatory bowel disease (IBD) and Crohn's disease.
Type:
Grant
Filed:
November 26, 2002
Date of Patent:
April 2, 2013
Assignees:
Trustees of Tufts College, Brigham & Women's Hospital
Inventors:
William W. Bachovchin, Vijay K. Kuchroo
Abstract: Patterned laser treatment of the retina is provided. A visible alignment pattern having at least two separated spots is projected onto the retina. By triggering a laser subsystem, doses of laser energy are automatically provided to at least two treatment locations coincident with the alignment spots. All of the doses of laser energy may be delivered in less than about 1 second, which is a typical eye fixation time. A scanner can be used to sequentially move an alignment beam from spot to spot on the retina and to move a treatment laser beam from location to location on the retina.
Type:
Grant
Filed:
June 11, 2010
Date of Patent:
April 2, 2013
Assignee:
The Board of Trustees of the Leland Stanford Junior University
Inventors:
Mark S. Blumenkranz, Daniel V. Palanker, Dimitri Yellachich
Abstract: An embodiment of the present invention is a method for resolving long-range haplotype phase based on family pedigree data, inheritance state determination, and population linkage disequilibrium data. A method according to an embodiment of the present invention provides for the evaluation of genome wide risk using phased haplotype data.
Type:
Application
Filed:
April 13, 2012
Publication date:
March 28, 2013
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Inventors:
Frederick Dewey, Euan A. Ashley, Matthew Wheeler, Sergio Cordero, Colleen Caleshu, Kelly Ormond
Abstract: The invention provides methods for treating or reducing the risk of developing acute lung injury manifested by increased vascular permeability. Also provided are pharmaceutical compositions comprising an FTY720 analog or derivative and/or SEW 2871 for use in the disclosed methods. The invention also provides methods for treating or reducing the risk of developing acute lung injury resulting from dysregulation of ceramide/sphingolipid pathway, more specifically, acute lung injury resulting from radiation.
Type:
Application
Filed:
March 3, 2011
Publication date:
March 28, 2013
Applicant:
The Board of Trustees of the University of Illinois
Abstract: An improved braking system is disclosed in which a pair of conical braking members engage a pair of skate wheels through vertical movement of a pushrod that is actuated by movement of the skater's foot within a cuff. The braking members are separated by a spring disposed on an axel to maintain the braking members in optimal braking position. The braking members are serrated to promote frictional contact with the wheels, and a disk is positioned on the axel to act as a clutch to control the braking force.
Type:
Application
Filed:
September 21, 2012
Publication date:
March 28, 2013
Applicant:
Alexander Bellehumeur, Trustee of the Alex Bellehumeur Family Trust
Inventor:
Alexander Bellehumeur, Trustee of the Alex Belleh
Abstract: Characteristics of a chemical or biological sample are detected using an approach involving light detection. According to an example embodiment of the present invention, an assaying arrangement including a light detector is adapted to detect light from a sample, such as a biological material. A signal corresponding to the detected light is used to characterize the sample, for example, by detecting a light-related property thereof. In one implementation, the assaying arrangement includes integrated circuitry having a light detector and a programmable processor, with the light detector generating a signal corresponding to the light and sending the signal to the processor. The processor provides an output corresponding to the signal and indicative of a characteristic of the sample.
Type:
Application
Filed:
November 19, 2012
Publication date:
March 28, 2013
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Inventor:
The Board of Trustees of the Leland Stanford Junio
Abstract: An embodiment of the present invention is a methodology for prioritizing variants relevant to inherited Mendelian (“single gene”) disease syndromes according to disease phenotype, gene, and variant level information.
Type:
Application
Filed:
April 13, 2012
Publication date:
March 28, 2013
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Inventors:
Frederick Dewey, Euan Ashley, Carlos Daniel Bustamante, Atul Butte, Jake Byrnes, Rong Chen
Abstract: A capital asset planning system for selecting assets for improvement within an infrastructure that includes one or more data sources descriptive of the infrastructure, one or more databases, coupled to the one or more data sources, to compile the one or more data sources, one or more processors, each coupled to and having respective communication interfaces to receive data from the one or more databases. The processor includes a predictor to generate a first metric of estimated infrastructure effectiveness based, at least in part, on a current status of the infrastructure, a second metric of estimated infrastructure effectiveness based, at least in part, on a user-selected, proposed changed configuration of the infrastructure, and a net metric of infrastructure effectiveness based, at least in part, on said first metric and said second metric.
Type:
Application
Filed:
October 8, 2012
Publication date:
March 28, 2013
Applicants:
Consolidated Edison Energy Company of New York, The Trustees of Columbia University in the City of New York
Inventors:
The Trustees of Columbia University in the City, Consolidated Edison Energy Company of New Yor
Abstract: A floral sleeve having a body and an insert or extension attached thereto is used to cover a pot. The sleeve may have a detachable upper portion for enclosing a floral grouping disposed within the pot.
Type:
Application
Filed:
November 15, 2012
Publication date:
March 28, 2013
Applicant:
Wanda M. Weder and William F. Straeter, not individually but solely as Trustees of The Family
Inventor:
Wanda M. Weder and William F. Straeter, not ind
Abstract: Embodiments described herein provide novel bacterial-based methods, systems, and delivery vehicles capable of delivering DNA, RNA, proteins, and other cargo into targeted mammalian cells, both in vitro and in vivo, with high efficiency. Delivery vehicles may be used to deliver molecules such as prophylactic or therapeutic proteins, DNA, shRNA, DNA vaccines, mucosal vaccines, modified viruses or viral components, and other bioactive molecules. Potential applications include gene therapy, wound healing therapies, cancer therapy, immune modulation, and research applications for which delivery of DNA, RNA, proteins, or other cargo into mammalian cells and tissues is required.
Type:
Application
Filed:
May 25, 2011
Publication date:
March 28, 2013
Applicant:
The Board of Trustees of the University of Illinois
Abstract: A method according to an embodiment of the present invention determines putative changes in splicing, mRNA structure, and protein synthesis. For each of these concepts, scoring algorithms are disclosed that can be used in a genome-wide scale. The described methods provide a pipeline that can be used to analyze the biological effects of SNPs generally, both synonymous and non-synonymous.
Type:
Application
Filed:
June 1, 2012
Publication date:
March 28, 2013
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Inventors:
Sergio Pablo Sánchez Cordero, Matthew Wheeler, Euan Ashley
Abstract: TSG101 is a tumor susceptibility gene whose homozygous functional knock out in fibroblasts leads to transformation and the ability of these cells to form metastatic tumors in nude mice. The cellular transformation that results from inactivation of TSG101 is reversible by restoration of TSG101 function. Decreased expression of TSG101 is associated with the occurrence of certain human cancers, including breast carcinomas. The TSG101 nucleic acid compositions find use in identifying homologous or related proteins and the DNA sequences encoding such proteins; in producing compositions that modulate the expression or function of the protein; and in studying associated physiological pathways. In addition, modulation of the gene activity in vivo is used for prophylactic and therapeutic purposes, such as treatment of cancer, identification of cell type based on expression, and the like.
Type:
Grant
Filed:
May 26, 2011
Date of Patent:
March 26, 2013
Assignee:
The Board of Trustees of the Leland Stanford Junior University